Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cardiac Devices
First European commercial implant of aortic stentless tissue valve performed
January 13th, 2005
St. Jude Medical, Inc. (STJ) announced the first commercial European implant of the Toronto SPV II tissue heart valve, the company's aortic stentless tissue valve. The implant was performed at Hospital Puerta del Mar in Cadiz, Spain, by Jose M(a) Jimenez Moreno, MD, chief, cardiac surgery, and assisted by Tomas Daroca, MD, and Miguel Angel Gomez Vidal, MD, both cardiac surgeons. The patient, a 76-year-old female, diagnosed with aortic stenosis (narrowing of the aortic valve). The St. Jude Medical Toronto SPV II with BiLinx AC valve builds on the durability and low complication rates of the Toronto SPV tissue valve, with the...
Source: Women's Health Weekly (2005-01-13)
|
